DiogenX
Entry
–
Hold
–
Status
Active
Who owns DiogenX?
DiogenX is currently owned by Aloe Private Equity through Sorbonne Venture (2022 vintage). Across its history, DiogenX has been through 5 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Aloe Private EquitySorbonne Venture · 2022 · VC
5 ownership periods · full history below
Key facts
HQFrance
SectorBiotech
Key takeaways
- ·Co-held by Boehringer Ingelheim Venture Fund, AdBio Partners, Omnes Capital, Sunstone Life Science Ventures and Aloe Private Equity since 2020.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Active
Co-held by Boehringer Ingelheim Venture Fund, AdBio Partners, Omnes Capital, Sunstone Life Science Ventures and Aloe Private Equity since 2020.
Co-invest · 4 holders · 2020 · present
AdBio PartnersActive
2020 · present(6yr) · AFB Fund II · 2021 · VC
Omnes CapitalActive
2023 · present(3yr) · Omnes Real Tech 1 · 2018 · VC
Aloe Private EquityActive
present · Sorbonne Venture · 2022 · VC
More from Sorbonne Venture
Other portfolio companies in the same fund.
France
Track DiogenX
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy DiogenX?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on DiogenX.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue